title: [Gastric Mucosa-associated Lymphoid Tissue Lymphoma Based on Outcome of Domestic Treatment].
abstract: Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is associated withHelicobacter pyloriinfection.H. pylorieradication can be performed as a primary therapy regardless ofH. pyloristatus. In Korea, six articles were published about low-grade gastric MALT lymphoma withH. pylori. Complete regression rate afterH. pylorieradication is reported at 74.5% to 94.4%. Radiotherapy results in favorable clinical long-term outcomes in patients with early-stage gastric MALT lymphoma who failH. pylorieradication therapy and those who areH. pylorinegative. Chemotherapy could be reserved for patients with metastatic or high-grade lymphoma. In gastric MALT lymphoma, patients with polypoid type on initial endoscopy had a higher likelihood of recurrence than those with diffuse infiltration or ulceration types. The depth of invasion, location of lesions, and chromosomal abnormality with t(11;18) together are predictive factors for failure to remission byH. pylorieradication.
authors: Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea.
authors: Jin Tae
authors: JT
authors: Jung
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005753:Gastric Mucosa / Q000473:pathology*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000473:pathology / Q000628:therapy*; D013274:Stomach Neoplasms / Q000150:complications / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents
keywords: Mucosa-associated lymphoid tissue; Stomach; Therapy